NCT01744353 - BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

August 31, 2015

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG

Dose level 1

Abraxane 125 mg/m2 day 1, Oxaliplatin 85 mg/m2 day 1, leuocovorin 400 mg/m2 day 1, F-FU infusion 1200 mg/m2 day x 2 days IV infusion

DRUG

Dose level 2/MTD

Abraxane 150 mg/m2 day 1, Oxaliplatin 85 mg/m2 day 1, leuocovorin 400 mg/m2 day 1, F-FU infusion 1200 mg/m2 day x 2 days IV infusion

DRUG

Dose level 3

Abraxane 175 mg/m2 day 1, Oxaliplatin 85 mg/m2 day 1, leuocovorin 400 mg/m2 day 1, F-FU infusion 1200 mg/m2 day x 2 days IV infusion

Trial Locations (3)

Memorial Hospital, Pawtucket

Rhode Island Hospital (including Newport and East Greenwich locations), Providence

The Miriam Hospital, Providence